Follows people with ankle arthritis after a Vantage total ankle implant
Follows adults who received a Vantage ankle implant for arthritis for up to 10 years.
Plain-language title generated from the registry record
Registry title: Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US)
Key facts
- Where
- Basel, SwitzerlandSee the site
Where in Switzerland
- SWISS ORTHO CENTER Pain Clinic BaselBasel, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Exactech
- Trial code
- NCT05691868
- Record updated
- 16 September 2026
- Original description
The objectives of this study are to evaluate the performance and safety of the Vantage Mobile-Bearing Total Angle System. This study will follow subjects for a period of up to 10 years post-surgery.Read full original descriptionShow less
An Open Label, Multi-Center, Single Arm Prospective Evaluation of Exactech Vantage Total Ankle System (Outside US)
The objectives of this study are to evaluate the performance and safety of the Vantage Mobile-Bearing Total Angle System. This study will follow subjects for a period of up to 10 years post-surgery.
Inclusion: Patient is indicated for total ankle arthroplasty; Patient is at least 21 years of age; Patient is likely to be available for follow-up out to 10 years; Patient is willing to participate by complying with pre- and postoperative visit requirements; Patient is willing and able to read and sign a study informed consent form.
Exclusion: Patient with infection at the ankle site or infection at distant sites that could migrate to the ankle; Patient with neurological or musculoskeletal disease or loss of function that may adversely affect movement of the lower limb, gait, or weight bearing; Patient with dementia; Patient with known metal allergies; Skeletally immature patients (patient is less than 21 years if age at time of surgery); Patient with excessive bone loss at the ankle joint site; Patient with severe osteoporosis; Patient with complete talar avascular necrosis; Patient with active osteomyelitis; Patient with sepsis; Patient with vascular deficiency in the involved limb; Pateint with neuropathic joints; Patient with poor soft tissue coverage around the ankle; Patient with Charcot arthropathy; Previsous ankle arthrodesis with excision of the malleoli; Excessive loads as cuased by activity or patient weight - per investigator discretion; Patients who are unwilling to provide informed consent; Patients who are unlikely to be available for follow-up out to 10 years; Patients who are not deemed suitable candidates for the subject device; Patient is pregnant.